Overview
Early-stage venture capital firm addressing critical problems with technolo
Founded
2019
Deals ยท 12mo
6
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Beren Therapeutics | Jun 2026Participated | $245 MOther Equity | |
Reprogram Biosciences | May 2026Participated | $6 MSeed | |
True Anomaly | Apr 2026Participated | $650 MSeries D | |
Chapter | Apr 2026Participated | $100 MSeries E | |
Valinor Enterprises | Jan 2026Participated | $54 MSeries A | |
Peptilogics | Oct 2025Participated | $78 MSeries B | |
Atomic Industries | Sep 2025Participated | $25 MSeries A | |
Kriya Therapeutics | Sep 2025Participated | $320 MSeries D | |
True Anomaly | Apr 2025Participated | $260 MSeries C | |
Chapter | Apr 2025Participated | $75 MSeries D | |
Strive Enterprises | Jul 2024Participated | $30 MSeries B | |
Strive | Jul 2024Participated | $30 MSeries B | |
Beren Therapeutics | Jun 2026Participated | $245 MOther Equity | |
Reprogram Biosciences | May 2026Participated | $6 MSeed | |
True Anomaly | Apr 2026Participated | $650 MSeries D | |
Chapter | Apr 2026Participated | $100 MSeries E | |
Valinor Enterprises | Jan 2026Participated | $54 MSeries A | |
Peptilogics | Oct 2025Participated | $78 MSeries B | |
Atomic Industries | Sep 2025Participated | $25 MSeries A | |
Kriya Therapeutics | Sep 2025Participated | $320 MSeries D | |
True Anomaly | Apr 2025Participated | $260 MSeries C | |
Chapter | Apr 2025Participated | $75 MSeries D | |
Strive Enterprises | Jul 2024Participated | $30 MSeries B | |
Strive | Jul 2024Participated | $30 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 2 | 2 |
| Series A | 1 | 5 |
| Series B | 0 | 7 |
| Series C+ | 1 | 9 |
| Other Equity | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| May '20 | 1 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 1 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 1 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 1 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 1 |
| Dec '21 | 0 |
| Jan '22 | 1 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 2 |
| Jun '22 | 2 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 1 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 2 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 1 |
| Jul '24 | 2 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 2 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 2 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 2 |
| May '26 | 1 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 15 |
| Fintech | 10 |
| Space & Frontier Tech | 10 |
| Consumer & Lifestyle | 7 |
| Manufacturing | 6 |
| AI & Machine Learning | 6 |
| Government & Defense | 5 |
| Crypto & Blockchain | 2 |
| Food & Agriculture | 2 |
| Real Estate & Construction | 2 |
| Data, Analytics & IT | 2 |
| Networks, Cloud & Communication | 1 |
| Enterprise Software | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 2 |
| $10M-$25M | 5 |
| $25M-$50M | 6 |
| $50M-$100M | 5 |
| $100M-$250M | 6 |
| $250M-$500M | 3 |
| $500M-$1B | 1 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 27 |
| 43215-3403 | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Susa Ventures | 6 |
| XYZ Venture Capital | 6 |
| Maverick Ventures | 5 |
| Addition | 4 |
| Eclipse Ventures | 4 |
| Founders Fund | 4 |
| Riot Ventures | 4 |
| 645 Ventures | 3 |
| ACME Capital | 3 |
| Bluebird Ventures | 3 |
| Champion Hill Ventures | 3 |
| Dexcel Pharma | 3 |
| Foresite Capital | 3 |
| Menlo Ventures | 3 |
| Patient Square Capital | 3 |
| QVT | 3 |
| Space.VC | 3 |
| Transhuman Capital | 3 |
| Accel | 2 |
| Acrew Capital | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 4 | 14% |
| Participating | 24 | 86% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 3 | 75% |
| Co-led | 1 | 25% |
Team
Co-Founder & Partner
Partner
Partner
Co-Founder and Partner